Global Microbiome Therapies Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Microbiome is a collective genome of microorganisms that reside inside and outside of the body, ranging from pathogenic to beneficial.
According to our (Global Info Research) latest study, the global Microbiome Therapies market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Microbiome Therapies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Microbiome Therapies market size and forecasts, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microbiome Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microbiome Therapies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uBiome, Evolve BioSystems, Indigo Agriculture, Pivot Bio and Concentric Ag, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Microbiome Therapies market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Microbiome Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microbiome Therapies, with revenue, gross margin and global market share of Microbiome Therapies from 2018 to 2023.
Chapter 3, the Microbiome Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Microbiome Therapies market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Microbiome Therapies.
Chapter 13, to describe Microbiome Therapies research findings and conclusion.
According to our (Global Info Research) latest study, the global Microbiome Therapies market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Microbiome Therapies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Microbiome Therapies market size and forecasts, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microbiome Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microbiome Therapies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uBiome, Evolve BioSystems, Indigo Agriculture, Pivot Bio and Concentric Ag, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Microbiome Therapies market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Bacteria
- Fungi
- Virus
- Others
- Testing Centres
- Research Labs
- Horticulture
- Others
- uBiome
- Evolve BioSystems
- Indigo Agriculture
- Pivot Bio
- Concentric Ag
- Epibiome
- CosmosID
- Human Longevity
- Ajinomoto Cambrooke
- AnimalBiome
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Microbiome Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microbiome Therapies, with revenue, gross margin and global market share of Microbiome Therapies from 2018 to 2023.
Chapter 3, the Microbiome Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Microbiome Therapies market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Microbiome Therapies.
Chapter 13, to describe Microbiome Therapies research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Microbiome Therapies
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microbiome Therapies by Type
1.3.1 Overview: Global Microbiome Therapies Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Microbiome Therapies Consumption Value Market Share by Type in 2022
1.3.3 Bacteria
1.3.4 Fungi
1.3.5 Virus
1.3.6 Others
1.4 Global Microbiome Therapies Market by Application
1.4.1 Overview: Global Microbiome Therapies Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Testing Centres
1.4.3 Research Labs
1.4.4 Horticulture
1.4.5 Others
1.5 Global Microbiome Therapies Market Size & Forecast
1.6 Global Microbiome Therapies Market Size and Forecast by Region
1.6.1 Global Microbiome Therapies Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Microbiome Therapies Market Size by Region, (2018-2029)
1.6.3 North America Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.4 Europe Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.6 South America Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Microbiome Therapies Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 uBiome
2.1.1 uBiome Details
2.1.2 uBiome Major Business
2.1.3 uBiome Microbiome Therapies Product and Solutions
2.1.4 uBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 uBiome Recent Developments and Future Plans
2.2 Evolve BioSystems
2.2.1 Evolve BioSystems Details
2.2.2 Evolve BioSystems Major Business
2.2.3 Evolve BioSystems Microbiome Therapies Product and Solutions
2.2.4 Evolve BioSystems Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Evolve BioSystems Recent Developments and Future Plans
2.3 Indigo Agriculture
2.3.1 Indigo Agriculture Details
2.3.2 Indigo Agriculture Major Business
2.3.3 Indigo Agriculture Microbiome Therapies Product and Solutions
2.3.4 Indigo Agriculture Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Indigo Agriculture Recent Developments and Future Plans
2.4 Pivot Bio
2.4.1 Pivot Bio Details
2.4.2 Pivot Bio Major Business
2.4.3 Pivot Bio Microbiome Therapies Product and Solutions
2.4.4 Pivot Bio Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pivot Bio Recent Developments and Future Plans
2.5 Concentric Ag
2.5.1 Concentric Ag Details
2.5.2 Concentric Ag Major Business
2.5.3 Concentric Ag Microbiome Therapies Product and Solutions
2.5.4 Concentric Ag Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Concentric Ag Recent Developments and Future Plans
2.6 Epibiome
2.6.1 Epibiome Details
2.6.2 Epibiome Major Business
2.6.3 Epibiome Microbiome Therapies Product and Solutions
2.6.4 Epibiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Epibiome Recent Developments and Future Plans
2.7 CosmosID
2.7.1 CosmosID Details
2.7.2 CosmosID Major Business
2.7.3 CosmosID Microbiome Therapies Product and Solutions
2.7.4 CosmosID Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CosmosID Recent Developments and Future Plans
2.8 Human Longevity
2.8.1 Human Longevity Details
2.8.2 Human Longevity Major Business
2.8.3 Human Longevity Microbiome Therapies Product and Solutions
2.8.4 Human Longevity Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Human Longevity Recent Developments and Future Plans
2.9 Ajinomoto Cambrooke
2.9.1 Ajinomoto Cambrooke Details
2.9.2 Ajinomoto Cambrooke Major Business
2.9.3 Ajinomoto Cambrooke Microbiome Therapies Product and Solutions
2.9.4 Ajinomoto Cambrooke Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ajinomoto Cambrooke Recent Developments and Future Plans
2.10 AnimalBiome
2.10.1 AnimalBiome Details
2.10.2 AnimalBiome Major Business
2.10.3 AnimalBiome Microbiome Therapies Product and Solutions
2.10.4 AnimalBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AnimalBiome Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Microbiome Therapies Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Microbiome Therapies by Company Revenue
3.2.2 Top 3 Microbiome Therapies Players Market Share in 2022
3.2.3 Top 6 Microbiome Therapies Players Market Share in 2022
3.3 Microbiome Therapies Market: Overall Company Footprint Analysis
3.3.1 Microbiome Therapies Market: Region Footprint
3.3.2 Microbiome Therapies Market: Company Product Type Footprint
3.3.3 Microbiome Therapies Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Microbiome Therapies Consumption Value and Market Share by Type (2018-2023)
4.2 Global Microbiome Therapies Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Microbiome Therapies Consumption Value Market Share by Application (2018-2023)
5.2 Global Microbiome Therapies Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Microbiome Therapies Consumption Value by Type (2018-2029)
6.2 North America Microbiome Therapies Consumption Value by Application (2018-2029)
6.3 North America Microbiome Therapies Market Size by Country
6.3.1 North America Microbiome Therapies Consumption Value by Country (2018-2029)
6.3.2 United States Microbiome Therapies Market Size and Forecast (2018-2029)
6.3.3 Canada Microbiome Therapies Market Size and Forecast (2018-2029)
6.3.4 Mexico Microbiome Therapies Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Microbiome Therapies Consumption Value by Type (2018-2029)
7.2 Europe Microbiome Therapies Consumption Value by Application (2018-2029)
7.3 Europe Microbiome Therapies Market Size by Country
7.3.1 Europe Microbiome Therapies Consumption Value by Country (2018-2029)
7.3.2 Germany Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.3 France Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.5 Russia Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.6 Italy Microbiome Therapies Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Microbiome Therapies Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Microbiome Therapies Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Microbiome Therapies Market Size by Region
8.3.1 Asia-Pacific Microbiome Therapies Consumption Value by Region (2018-2029)
8.3.2 China Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.3 Japan Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.4 South Korea Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.5 India Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.7 Australia Microbiome Therapies Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Microbiome Therapies Consumption Value by Type (2018-2029)
9.2 South America Microbiome Therapies Consumption Value by Application (2018-2029)
9.3 South America Microbiome Therapies Market Size by Country
9.3.1 South America Microbiome Therapies Consumption Value by Country (2018-2029)
9.3.2 Brazil Microbiome Therapies Market Size and Forecast (2018-2029)
9.3.3 Argentina Microbiome Therapies Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Microbiome Therapies Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Microbiome Therapies Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Microbiome Therapies Market Size by Country
10.3.1 Middle East & Africa Microbiome Therapies Consumption Value by Country (2018-2029)
10.3.2 Turkey Microbiome Therapies Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Microbiome Therapies Market Size and Forecast (2018-2029)
10.3.4 UAE Microbiome Therapies Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Microbiome Therapies Market Drivers
11.2 Microbiome Therapies Market Restraints
11.3 Microbiome Therapies Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Microbiome Therapies Industry Chain
12.2 Microbiome Therapies Upstream Analysis
12.3 Microbiome Therapies Midstream Analysis
12.4 Microbiome Therapies Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Microbiome Therapies
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microbiome Therapies by Type
1.3.1 Overview: Global Microbiome Therapies Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Microbiome Therapies Consumption Value Market Share by Type in 2022
1.3.3 Bacteria
1.3.4 Fungi
1.3.5 Virus
1.3.6 Others
1.4 Global Microbiome Therapies Market by Application
1.4.1 Overview: Global Microbiome Therapies Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Testing Centres
1.4.3 Research Labs
1.4.4 Horticulture
1.4.5 Others
1.5 Global Microbiome Therapies Market Size & Forecast
1.6 Global Microbiome Therapies Market Size and Forecast by Region
1.6.1 Global Microbiome Therapies Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Microbiome Therapies Market Size by Region, (2018-2029)
1.6.3 North America Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.4 Europe Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.6 South America Microbiome Therapies Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Microbiome Therapies Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 uBiome
2.1.1 uBiome Details
2.1.2 uBiome Major Business
2.1.3 uBiome Microbiome Therapies Product and Solutions
2.1.4 uBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 uBiome Recent Developments and Future Plans
2.2 Evolve BioSystems
2.2.1 Evolve BioSystems Details
2.2.2 Evolve BioSystems Major Business
2.2.3 Evolve BioSystems Microbiome Therapies Product and Solutions
2.2.4 Evolve BioSystems Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Evolve BioSystems Recent Developments and Future Plans
2.3 Indigo Agriculture
2.3.1 Indigo Agriculture Details
2.3.2 Indigo Agriculture Major Business
2.3.3 Indigo Agriculture Microbiome Therapies Product and Solutions
2.3.4 Indigo Agriculture Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Indigo Agriculture Recent Developments and Future Plans
2.4 Pivot Bio
2.4.1 Pivot Bio Details
2.4.2 Pivot Bio Major Business
2.4.3 Pivot Bio Microbiome Therapies Product and Solutions
2.4.4 Pivot Bio Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pivot Bio Recent Developments and Future Plans
2.5 Concentric Ag
2.5.1 Concentric Ag Details
2.5.2 Concentric Ag Major Business
2.5.3 Concentric Ag Microbiome Therapies Product and Solutions
2.5.4 Concentric Ag Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Concentric Ag Recent Developments and Future Plans
2.6 Epibiome
2.6.1 Epibiome Details
2.6.2 Epibiome Major Business
2.6.3 Epibiome Microbiome Therapies Product and Solutions
2.6.4 Epibiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Epibiome Recent Developments and Future Plans
2.7 CosmosID
2.7.1 CosmosID Details
2.7.2 CosmosID Major Business
2.7.3 CosmosID Microbiome Therapies Product and Solutions
2.7.4 CosmosID Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CosmosID Recent Developments and Future Plans
2.8 Human Longevity
2.8.1 Human Longevity Details
2.8.2 Human Longevity Major Business
2.8.3 Human Longevity Microbiome Therapies Product and Solutions
2.8.4 Human Longevity Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Human Longevity Recent Developments and Future Plans
2.9 Ajinomoto Cambrooke
2.9.1 Ajinomoto Cambrooke Details
2.9.2 Ajinomoto Cambrooke Major Business
2.9.3 Ajinomoto Cambrooke Microbiome Therapies Product and Solutions
2.9.4 Ajinomoto Cambrooke Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ajinomoto Cambrooke Recent Developments and Future Plans
2.10 AnimalBiome
2.10.1 AnimalBiome Details
2.10.2 AnimalBiome Major Business
2.10.3 AnimalBiome Microbiome Therapies Product and Solutions
2.10.4 AnimalBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AnimalBiome Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Microbiome Therapies Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Microbiome Therapies by Company Revenue
3.2.2 Top 3 Microbiome Therapies Players Market Share in 2022
3.2.3 Top 6 Microbiome Therapies Players Market Share in 2022
3.3 Microbiome Therapies Market: Overall Company Footprint Analysis
3.3.1 Microbiome Therapies Market: Region Footprint
3.3.2 Microbiome Therapies Market: Company Product Type Footprint
3.3.3 Microbiome Therapies Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Microbiome Therapies Consumption Value and Market Share by Type (2018-2023)
4.2 Global Microbiome Therapies Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Microbiome Therapies Consumption Value Market Share by Application (2018-2023)
5.2 Global Microbiome Therapies Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Microbiome Therapies Consumption Value by Type (2018-2029)
6.2 North America Microbiome Therapies Consumption Value by Application (2018-2029)
6.3 North America Microbiome Therapies Market Size by Country
6.3.1 North America Microbiome Therapies Consumption Value by Country (2018-2029)
6.3.2 United States Microbiome Therapies Market Size and Forecast (2018-2029)
6.3.3 Canada Microbiome Therapies Market Size and Forecast (2018-2029)
6.3.4 Mexico Microbiome Therapies Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Microbiome Therapies Consumption Value by Type (2018-2029)
7.2 Europe Microbiome Therapies Consumption Value by Application (2018-2029)
7.3 Europe Microbiome Therapies Market Size by Country
7.3.1 Europe Microbiome Therapies Consumption Value by Country (2018-2029)
7.3.2 Germany Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.3 France Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.5 Russia Microbiome Therapies Market Size and Forecast (2018-2029)
7.3.6 Italy Microbiome Therapies Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Microbiome Therapies Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Microbiome Therapies Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Microbiome Therapies Market Size by Region
8.3.1 Asia-Pacific Microbiome Therapies Consumption Value by Region (2018-2029)
8.3.2 China Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.3 Japan Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.4 South Korea Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.5 India Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Microbiome Therapies Market Size and Forecast (2018-2029)
8.3.7 Australia Microbiome Therapies Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Microbiome Therapies Consumption Value by Type (2018-2029)
9.2 South America Microbiome Therapies Consumption Value by Application (2018-2029)
9.3 South America Microbiome Therapies Market Size by Country
9.3.1 South America Microbiome Therapies Consumption Value by Country (2018-2029)
9.3.2 Brazil Microbiome Therapies Market Size and Forecast (2018-2029)
9.3.3 Argentina Microbiome Therapies Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Microbiome Therapies Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Microbiome Therapies Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Microbiome Therapies Market Size by Country
10.3.1 Middle East & Africa Microbiome Therapies Consumption Value by Country (2018-2029)
10.3.2 Turkey Microbiome Therapies Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Microbiome Therapies Market Size and Forecast (2018-2029)
10.3.4 UAE Microbiome Therapies Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Microbiome Therapies Market Drivers
11.2 Microbiome Therapies Market Restraints
11.3 Microbiome Therapies Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Microbiome Therapies Industry Chain
12.2 Microbiome Therapies Upstream Analysis
12.3 Microbiome Therapies Midstream Analysis
12.4 Microbiome Therapies Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Microbiome Therapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Microbiome Therapies Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Microbiome Therapies Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Microbiome Therapies Consumption Value by Region (2024-2029) & (USD Million)
Table 5. uBiome Company Information, Head Office, and Major Competitors
Table 6. uBiome Major Business
Table 7. uBiome Microbiome Therapies Product and Solutions
Table 8. uBiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. uBiome Recent Developments and Future Plans
Table 10. Evolve BioSystems Company Information, Head Office, and Major Competitors
Table 11. Evolve BioSystems Major Business
Table 12. Evolve BioSystems Microbiome Therapies Product and Solutions
Table 13. Evolve BioSystems Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Evolve BioSystems Recent Developments and Future Plans
Table 15. Indigo Agriculture Company Information, Head Office, and Major Competitors
Table 16. Indigo Agriculture Major Business
Table 17. Indigo Agriculture Microbiome Therapies Product and Solutions
Table 18. Indigo Agriculture Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Indigo Agriculture Recent Developments and Future Plans
Table 20. Pivot Bio Company Information, Head Office, and Major Competitors
Table 21. Pivot Bio Major Business
Table 22. Pivot Bio Microbiome Therapies Product and Solutions
Table 23. Pivot Bio Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Pivot Bio Recent Developments and Future Plans
Table 25. Concentric Ag Company Information, Head Office, and Major Competitors
Table 26. Concentric Ag Major Business
Table 27. Concentric Ag Microbiome Therapies Product and Solutions
Table 28. Concentric Ag Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Concentric Ag Recent Developments and Future Plans
Table 30. Epibiome Company Information, Head Office, and Major Competitors
Table 31. Epibiome Major Business
Table 32. Epibiome Microbiome Therapies Product and Solutions
Table 33. Epibiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Epibiome Recent Developments and Future Plans
Table 35. CosmosID Company Information, Head Office, and Major Competitors
Table 36. CosmosID Major Business
Table 37. CosmosID Microbiome Therapies Product and Solutions
Table 38. CosmosID Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. CosmosID Recent Developments and Future Plans
Table 40. Human Longevity Company Information, Head Office, and Major Competitors
Table 41. Human Longevity Major Business
Table 42. Human Longevity Microbiome Therapies Product and Solutions
Table 43. Human Longevity Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Human Longevity Recent Developments and Future Plans
Table 45. Ajinomoto Cambrooke Company Information, Head Office, and Major Competitors
Table 46. Ajinomoto Cambrooke Major Business
Table 47. Ajinomoto Cambrooke Microbiome Therapies Product and Solutions
Table 48. Ajinomoto Cambrooke Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Ajinomoto Cambrooke Recent Developments and Future Plans
Table 50. AnimalBiome Company Information, Head Office, and Major Competitors
Table 51. AnimalBiome Major Business
Table 52. AnimalBiome Microbiome Therapies Product and Solutions
Table 53. AnimalBiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. AnimalBiome Recent Developments and Future Plans
Table 55. Global Microbiome Therapies Revenue (USD Million) by Players (2018-2023)
Table 56. Global Microbiome Therapies Revenue Share by Players (2018-2023)
Table 57. Breakdown of Microbiome Therapies by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Microbiome Therapies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Microbiome Therapies Players
Table 60. Microbiome Therapies Market: Company Product Type Footprint
Table 61. Microbiome Therapies Market: Company Product Application Footprint
Table 62. Microbiome Therapies New Market Entrants and Barriers to Market Entry
Table 63. Microbiome Therapies Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Microbiome Therapies Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Microbiome Therapies Consumption Value Share by Type (2018-2023)
Table 66. Global Microbiome Therapies Consumption Value Forecast by Type (2024-2029)
Table 67. Global Microbiome Therapies Consumption Value by Application (2018-2023)
Table 68. Global Microbiome Therapies Consumption Value Forecast by Application (2024-2029)
Table 69. North America Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Microbiome Therapies Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Microbiome Therapies Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Microbiome Therapies Raw Material
Table 100. Key Suppliers of Microbiome Therapies Raw Materials
Table 1. Global Microbiome Therapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Microbiome Therapies Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Microbiome Therapies Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Microbiome Therapies Consumption Value by Region (2024-2029) & (USD Million)
Table 5. uBiome Company Information, Head Office, and Major Competitors
Table 6. uBiome Major Business
Table 7. uBiome Microbiome Therapies Product and Solutions
Table 8. uBiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. uBiome Recent Developments and Future Plans
Table 10. Evolve BioSystems Company Information, Head Office, and Major Competitors
Table 11. Evolve BioSystems Major Business
Table 12. Evolve BioSystems Microbiome Therapies Product and Solutions
Table 13. Evolve BioSystems Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Evolve BioSystems Recent Developments and Future Plans
Table 15. Indigo Agriculture Company Information, Head Office, and Major Competitors
Table 16. Indigo Agriculture Major Business
Table 17. Indigo Agriculture Microbiome Therapies Product and Solutions
Table 18. Indigo Agriculture Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Indigo Agriculture Recent Developments and Future Plans
Table 20. Pivot Bio Company Information, Head Office, and Major Competitors
Table 21. Pivot Bio Major Business
Table 22. Pivot Bio Microbiome Therapies Product and Solutions
Table 23. Pivot Bio Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Pivot Bio Recent Developments and Future Plans
Table 25. Concentric Ag Company Information, Head Office, and Major Competitors
Table 26. Concentric Ag Major Business
Table 27. Concentric Ag Microbiome Therapies Product and Solutions
Table 28. Concentric Ag Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Concentric Ag Recent Developments and Future Plans
Table 30. Epibiome Company Information, Head Office, and Major Competitors
Table 31. Epibiome Major Business
Table 32. Epibiome Microbiome Therapies Product and Solutions
Table 33. Epibiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Epibiome Recent Developments and Future Plans
Table 35. CosmosID Company Information, Head Office, and Major Competitors
Table 36. CosmosID Major Business
Table 37. CosmosID Microbiome Therapies Product and Solutions
Table 38. CosmosID Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. CosmosID Recent Developments and Future Plans
Table 40. Human Longevity Company Information, Head Office, and Major Competitors
Table 41. Human Longevity Major Business
Table 42. Human Longevity Microbiome Therapies Product and Solutions
Table 43. Human Longevity Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Human Longevity Recent Developments and Future Plans
Table 45. Ajinomoto Cambrooke Company Information, Head Office, and Major Competitors
Table 46. Ajinomoto Cambrooke Major Business
Table 47. Ajinomoto Cambrooke Microbiome Therapies Product and Solutions
Table 48. Ajinomoto Cambrooke Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Ajinomoto Cambrooke Recent Developments and Future Plans
Table 50. AnimalBiome Company Information, Head Office, and Major Competitors
Table 51. AnimalBiome Major Business
Table 52. AnimalBiome Microbiome Therapies Product and Solutions
Table 53. AnimalBiome Microbiome Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. AnimalBiome Recent Developments and Future Plans
Table 55. Global Microbiome Therapies Revenue (USD Million) by Players (2018-2023)
Table 56. Global Microbiome Therapies Revenue Share by Players (2018-2023)
Table 57. Breakdown of Microbiome Therapies by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Microbiome Therapies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Microbiome Therapies Players
Table 60. Microbiome Therapies Market: Company Product Type Footprint
Table 61. Microbiome Therapies Market: Company Product Application Footprint
Table 62. Microbiome Therapies New Market Entrants and Barriers to Market Entry
Table 63. Microbiome Therapies Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Microbiome Therapies Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Microbiome Therapies Consumption Value Share by Type (2018-2023)
Table 66. Global Microbiome Therapies Consumption Value Forecast by Type (2024-2029)
Table 67. Global Microbiome Therapies Consumption Value by Application (2018-2023)
Table 68. Global Microbiome Therapies Consumption Value Forecast by Application (2024-2029)
Table 69. North America Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Microbiome Therapies Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Microbiome Therapies Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Microbiome Therapies Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Microbiome Therapies Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Microbiome Therapies Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Microbiome Therapies Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Microbiome Therapies Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Microbiome Therapies Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Microbiome Therapies Raw Material
Table 100. Key Suppliers of Microbiome Therapies Raw Materials
LIST OF FIGURES
Figure 1. Microbiome Therapies Picture
Figure 2. Global Microbiome Therapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Microbiome Therapies Consumption Value Market Share by Type in 2022
Figure 4. Bacteria
Figure 5. Fungi
Figure 6. Virus
Figure 7. Others
Figure 8. Global Microbiome Therapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Microbiome Therapies Consumption Value Market Share by Application in 2022
Figure 10. Testing Centres Picture
Figure 11. Research Labs Picture
Figure 12. Horticulture Picture
Figure 13. Others Picture
Figure 14. Global Microbiome Therapies Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Microbiome Therapies Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Microbiome Therapies Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Microbiome Therapies Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Microbiome Therapies Consumption Value Market Share by Region in 2022
Figure 19. North America Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Microbiome Therapies Revenue Share by Players in 2022
Figure 25. Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Microbiome Therapies Market Share in 2022
Figure 27. Global Top 6 Players Microbiome Therapies Market Share in 2022
Figure 28. Global Microbiome Therapies Consumption Value Share by Type (2018-2023)
Figure 29. Global Microbiome Therapies Market Share Forecast by Type (2024-2029)
Figure 30. Global Microbiome Therapies Consumption Value Share by Application (2018-2023)
Figure 31. Global Microbiome Therapies Market Share Forecast by Application (2024-2029)
Figure 32. North America Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 42. France Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Microbiome Therapies Consumption Value Market Share by Region (2018-2029)
Figure 49. China Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 52. India Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 66. Microbiome Therapies Market Drivers
Figure 67. Microbiome Therapies Market Restraints
Figure 68. Microbiome Therapies Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Microbiome Therapies in 2022
Figure 71. Manufacturing Process Analysis of Microbiome Therapies
Figure 72. Microbiome Therapies Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Microbiome Therapies Picture
Figure 2. Global Microbiome Therapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Microbiome Therapies Consumption Value Market Share by Type in 2022
Figure 4. Bacteria
Figure 5. Fungi
Figure 6. Virus
Figure 7. Others
Figure 8. Global Microbiome Therapies Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Microbiome Therapies Consumption Value Market Share by Application in 2022
Figure 10. Testing Centres Picture
Figure 11. Research Labs Picture
Figure 12. Horticulture Picture
Figure 13. Others Picture
Figure 14. Global Microbiome Therapies Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Microbiome Therapies Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Microbiome Therapies Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Microbiome Therapies Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Microbiome Therapies Consumption Value Market Share by Region in 2022
Figure 19. North America Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Microbiome Therapies Revenue Share by Players in 2022
Figure 25. Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Microbiome Therapies Market Share in 2022
Figure 27. Global Top 6 Players Microbiome Therapies Market Share in 2022
Figure 28. Global Microbiome Therapies Consumption Value Share by Type (2018-2023)
Figure 29. Global Microbiome Therapies Market Share Forecast by Type (2024-2029)
Figure 30. Global Microbiome Therapies Consumption Value Share by Application (2018-2023)
Figure 31. Global Microbiome Therapies Market Share Forecast by Application (2024-2029)
Figure 32. North America Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 42. France Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Microbiome Therapies Consumption Value Market Share by Region (2018-2029)
Figure 49. China Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 52. India Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Microbiome Therapies Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Microbiome Therapies Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Microbiome Therapies Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Microbiome Therapies Consumption Value (2018-2029) & (USD Million)
Figure 66. Microbiome Therapies Market Drivers
Figure 67. Microbiome Therapies Market Restraints
Figure 68. Microbiome Therapies Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Microbiome Therapies in 2022
Figure 71. Manufacturing Process Analysis of Microbiome Therapies
Figure 72. Microbiome Therapies Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
